Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuemang Yao

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Neurobiology of Aging|August 26, 2006
The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus oldCinzia M Chinnici, Yuemang Yao, Domenico Praticò
Molecular Vision|March 1, 2007
Isoprostane F2alpha-VI, a new marker of oxidative stress, increases following light damage to the mouse retinaTzvete Dentchev, Yuemang Yao, Domenico Pratico, et al.
Atherosclerosis|December 6, 2005
Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirinTillmann Cyrus, Yuemang Yao, Liun X Tung, et al.
Archives of Neurology|August 16, 2006
Altered vascular phenotype in autism: correlation with oxidative stressYuemang Yao, William J Walsh, Woody R McGinnis, et al.
Circulation|November 4, 2005
Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient miceMyan Tang, Tillmann Cyrus, Yuemang Yao, et al.
Blood|December 13, 2006
Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO miceTillmann Cyrus, Yuemang Yao, Tao Ding, et al.
The American Journal of Pathology|October 28, 2005
Absence of 12/15 lipoxygenase reduces brain oxidative stress in apolipoprotein E-deficient miceCinzia M Chinnici, Yuemang Yao, Tao Ding, et al.
Circulation|February 5, 2003
Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesionsTillmann Cyrus, Yuemang Yao, Joshua Rokach, et al.
European Journal of Pharmacology|February 20, 2007
A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient miceTillmann Cyrus, Yuemang Yao, Tao Ding, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 2, 2025
HDAC6 Inhibition Reduces Seeded Tau and α-Synuclein Pathologies in Primary Neuron Cultures and Wild-type MiceAlex Crowe, Yuemang Yao, Mira Newman, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Neurobiology of Aging|August 26, 2006
The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus oldCinzia M Chinnici, Yuemang Yao, Domenico Praticò
Molecular Vision|March 1, 2007
Isoprostane F2alpha-VI, a new marker of oxidative stress, increases following light damage to the mouse retinaTzvete Dentchev, Yuemang Yao, Domenico Pratico, et al.
Atherosclerosis|December 6, 2005
Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirinTillmann Cyrus, Yuemang Yao, Liun X Tung, et al.
Archives of Neurology|August 16, 2006
Altered vascular phenotype in autism: correlation with oxidative stressYuemang Yao, William J Walsh, Woody R McGinnis, et al.
Circulation|November 4, 2005
Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient miceMyan Tang, Tillmann Cyrus, Yuemang Yao, et al.
Blood|December 13, 2006
Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO miceTillmann Cyrus, Yuemang Yao, Tao Ding, et al.
The American Journal of Pathology|October 28, 2005
Absence of 12/15 lipoxygenase reduces brain oxidative stress in apolipoprotein E-deficient miceCinzia M Chinnici, Yuemang Yao, Tao Ding, et al.
Circulation|February 5, 2003
Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesionsTillmann Cyrus, Yuemang Yao, Joshua Rokach, et al.
European Journal of Pharmacology|February 20, 2007
A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient miceTillmann Cyrus, Yuemang Yao, Tao Ding, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 2, 2025
HDAC6 Inhibition Reduces Seeded Tau and α-Synuclein Pathologies in Primary Neuron Cultures and Wild-type MiceAlex Crowe, Yuemang Yao, Mira Newman, et al.
Pageof 4